Neurofeedback insurance

Neurofeedback insurance is a form of health coverage that reimburses policyholders for clinically necessary neurofeedback therapy, which insurers such as Aetna and UnitedHealthcare sometimes classify under mental health benefits. Most major insurers require a diagnosis like ADHD or epilepsy to approve neurofeedback claims, referencing ICD-10 codes (e.g.

F90.0 for ADHD). Providers must submit detailed clinical documentation and CPT code 90901 or 90876 for coverage consideration by Blue Cross Blue Shield and Cigna.

Insurers generally deny neurofeedback reimbursement if billed for unapproved uses such as cognitive enhancement rather than medical treatment. Policy exclusions from Medicare and Medicaid list neurofeedback as “experimental” due to limited peer-reviewed evidence; only 5% of plans cover it for children with autism spectrum disorder.

Prior authorization requirements mandate physician referrals and pre-approval before sessions begin, documented in insurer provider manuals. Flexible spending accounts (FSAs) and health savings accounts (HSAs) often permit use of pretax dollars for neurofeedback when prescribed by a licensed clinician, confirmed by IRS Publication 502 examples.

Out-of-network benefits may partially reimburse sessions with unaffiliated providers, but patients pay upfront and submit claims, shown on EOB statements from Anthem and Humana. Coverage limits frequently cap the number of reimbursable sessions per year, averaging between 10–20 based on reviews of Cigna and Regence member handbooks, as described by the Insurance Information Database.

Appeals processes exist if claims are denied; success rates depend on submission of peer-reviewed studies supporting effectiveness for specific conditions, as referenced by Tricare guidelines. Deductibles and co-pays apply to covered neurofeedback services at standard rates listed in plan summary documents from companies like Kaiser Permanente.